Taken together, our results reveal that resveratrol has a therapeutic effect, which can regulate inflammation and oxidative stress via the activation of SIRT1 and their downstream targets, including PGC-1α in COPD rats. This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.